I-131-S-2
SODIUM IODIDE (131|)
| Name | SODIUM IODIDE (131I) CIS bio International |
| Pharmaceutical form | Solution for injection |
| Nuclide | Iodine 131 |
| Half life | 8.02 days |
| Availability | Thursday |
| Ordering deadline | 2 days before the shipment day, before 10 a.m. |
| Radioactive concentration | 111 MBq/mL |
| Calibration | Friday (following week) 12 a.m. |
| Available quantities | From 74 to 1110 MBq |
| Expiry | 29 days from the manufacturing date |
| Specific activity | ≥ 185 GBq/mg at calibration |
| Radiochemical purity | Iodide : ≥ 95 % ; Iodate + periodate ≤ 5% |
| Radionuclidic purity | ≥ 99.9 %; 133I + 135I + other alpha impurities ≤ 0.1 % |
| pH and composition | 6 - 8 in phosphate-thiosulfate buffer |
| Storage | Not above 25°C |
| Indication | Diagnostic • Estimation of thyroid uptake and effective half life • Identification of thyroid remnant and metastases (after ablation) Therapy • Treatment of Graves disease, toxic multinodular goitre or autonomous nodules • Treatment of papillary and follicular thyroid carcinoma including metastatic disease |
Support Solution
IBA does not provide pharmaceuticals... we do much more than that. Beyond the quality of our products and services you expect a leading radiopharmaceutical company to provide you with all the environment necessary to master our products and to operate your daily activity in a professional manner.
Our set of customer solutions includes :
- Product trainings
- Round tables facilitation
- Patient recruitment support
- ISS (Investigator Sponsored Studies)
- Organisations of symposiums
- Newsletters
